-
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)—an individual participant data meta-analysis
Schoof, L. G., Rød, B. E., el Mahdaoui, S., Michelsen, J. S., Høgestøl, E. A., Myhr, K.-M., Rise, H. H., Su, Z., Eriksson, F., Friede, T., Lundell, H., Sellebjerg, F., Sidaros, K., Siebner, H. R., Wiggermann, V., Jasperse, B., Lissenberg-Witte, B., van Oosten, B. W., Schoonheim, M. M. & Edan, G. & 7 others, , 1 Jan 2026, In: Multiple sclerosis and related disorders. 105, 106858.Research output: Contribution to journal › Article › Academic › peer-review
-
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Pennings, E. R. A., Spanjaart, A. M., Thielen, F. W., Oerlemans, S., Fleischer, A., Sanges, C., Gomes da Silva, M., Cabrerizo, Y., Lecot, P., Roux-Opstaele, L., Dreuillet, C., Gonzalez-Marcano, E., Millán, O., Jaeger, U., Delgado, J., Luu, M., Huber, B., Lorrain, M., Pina, M. & Kremer, A. & 18 others, , 23 Dec 2025, In: Blood. 9, 24, p. 6380-6393 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Identifying tests to evaluate in a diagnostic accuracy study for patients with vertigo in general practice: a Delphi study
Leemeyer, A.-M. R., Ross, A. K., Bruintjes, T. D., Cals, J. W. L., van Leeuwen, R. B., Lissenberg-Witte, B. I., van Vugt, V. A. & Maarsingh, O. R., 1 Dec 2025, In: BMC primary care. 26, 1, 238.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
